IMNM — Immunome Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Immunome, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	39.8	49.2	20.3	138	217
Net Total Receivables	—	—	0.847	0	—
Prepaid Expenses
Total Current Assets	42.9	56.6	22.6	145	221
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.53	0.855	0.965	3.64	14.4
Other Long Term Assets
Total Assets	44.5	57.9	24	149	240
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.04	9.73	7.33	21.8	54.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.18	9.74	7.39	28.7	59.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	41.3	48.2	16.7	120	181
Total Liabilities & Shareholders' Equity	44.5	57.9	24	149	240
Total Common Shares Outstanding